Gamunex-c Injection
Product Images NDC 13533-805

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Gamunex-c (NDC 13533-805). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Grifols Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bag (Bag1)

Bag (Bag1)
This is a description of Immune Globulin Injection (Human) - 10% Caprylate/Chromatography Purified, with NDC 13533-805-10. The product is presented in a single-dose flexible container for intravenous administration. It is important to discuss the risks and benefits of this product with a physician. Prior to use, check the container for leaks and do not use if turbid or if leaks are found. The product can be stored for up to 36 months at 2-8°C, with an option to store at temperatures not exceeding 25°C for up to 6 months within the 36-month shelf life. After this, the product must be used immediately or discarded. It should not be frozen. Manufacturer: Grifols Therapeutics LLC, located in Clayton, NC, USA.*
FDA Label Image

Carton (Carton1)

Carton (Carton1)
This text is a detailed description of Immune Globulin Injection (Human), 10%, Caprylate/Chromatography Purified gamunex-c flexbag solution for infusion. It mentions specific dosage information, administration instructions, and content details such as protein concentration. The text also includes NDC code and license information.*
FDA Label Image

Figure 1234 (Figure1234)

Figure 1234 (Figure1234)
FDA Label Image

Figure 8: Outcome Of Randomized Withdrawal Period (Gamunex Img 01)

Figure 8: Outcome Of Randomized Withdrawal Period (Gamunex Img 01)
This text provides data on the percentage of patients who relapsed and the time to relapse in a comparison between the treatment group (GAMUNEX with 31 patients) and the control group (Placebo with 26 patients). The chart shows the percentage of relapsed patients at different time points over weeks.*
FDA Label Image
Logo (Logo)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.